Inventor

ORDENTLICH PETER

US10 patents

⚠️ This page may combine multiple inventors who share the name “ORDENTLICH PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SYNDAX PHARMACEUTICALS INC

6 patents

US11397184B2Jul 26, 2022

Selection of patients for combination therapy

SYNDAX PHARMACEUTICALS INC2 citations69

US11324822B2May 10, 2022

Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer

SYNDAX PHARMACEUTICALS INC3 citations69

US12168054B2Dec 17, 2024

Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody

SYNDAX PHARMACEUTICALS INC0 citations60

US12552869B2Feb 17, 2026

CSF-1R antibodies for the treatment of chronic graft versus host disease

SYNDAX PHARMACEUTICALS INC0 citations58

US12000829B2Jun 4, 2024

Selection of patients for combination therapy

SYNDAX PHARMACEUTICALS INC0 citations56

US12564590B2Mar 3, 2026

Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof

SYNDAX PHARMACEUTICALS INC0 citations55

SALK INST FOR BIOLOGICAL STUDI

2 patents

US6673587B1Jan 6, 2004

Histone deacetylase, and uses therefor

SALK INST FOR BIOLOGICAL STUDI30 citations89

US7314747B1Jan 1, 2008

SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors

SALK INST FOR BIOLOGICAL STUDI1 citations60

GOODENOW ROBERT

1 patent

US10226472B2Mar 12, 2019

Methods for the treatment of breast cancer

GOODENOW ROBERT14 citations78

MARTIN RICHARD

1 patent

US8455489B2Jun 4, 2013

Substituted pyrimidine compositions and methods of use

MARTIN RICHARD1 citations51